TOPLINE: Early rituximab monotherapy led to a substantial delay in the need for new treatment in patients with advanced stage, asymptomatic, low tumour burden follicular lymphoma. […]
TOPLINE: Although remission rates of patients with early rheumatoid arthritis (RA) remained stable between 2018 and 2024 in England and Wales, regional differences were noted. Factors […]
TOPLINE: Headache and fatigue were the most commonly reported incident adverse events of the AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine in real-world settings across the United Kingdom; […]
SAN DIEGO — New hair, new problems: A pair of reports are shedding light on the growing danger posed to household pets by topical minoxidil (Rogaine), […]
TOPLINE: Younger patients with alopecia areata (AA) and those who have a history of acne were more likely to develop acne during Janus kinase inhibitor (JAKi) […]
TOPLINE: A study of 239,907 women from the Nurses’ Health Study (NHS) and NHS II examined cardiovascular disease (CVD) risk after hysterectomy with or without oophorectomy. […]
In the spring of 2024, the US Food and Drug Administration (FDA) approved fidanacogene elaparvovec (Beqvez), only the second gene therapy product for hemophilia B. Just […]
TOPLINE: In the multicenter PLATO-ACT4 trial, patients with early-stage anal cancer who received reduced-dose chemoradiotherapy had higher complete clinical response rates at 6 months and experienced […]
TOPLINE: Perioperative discontinuation of acetylsalicylic acid (ASA) treatment for 12 days was not associated with a reduction in 6-month recurrence of chronic subdural hematoma (cSDH) in […]
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPTReject
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.